Nanobiotix Shares Halted on Euronext Paris Ahead of Global Offering Pricing
NBTX has more than doubled off its 52-week low of $3.64.
Summary
Trading of Nanobiotix's ordinary shares on Euronext Paris has been temporarily halted at the company's request. This halt is in preparation for the pricing and allocation confirmation of a previously announced Global Offering, which includes a public offering of ADSs in the US and an offering of shares/warrants in Europe. This event is significant as it signals the imminent announcement of terms for a potentially dilutive capital raise. Trading is expected to resume later today, May 21, 2026, at approximately 3:30 p.m. Paris time, when the pricing details are anticipated.
At the time of this announcement, NBTX was trading at $40.14 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $3.64 to $57.14. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.